The American Council of Cannabis Medicine is partnering with insurers, health systems, and wellness organizations to expand medically guided cannabis access. This collaboration marks a major step toward integrating cannabis into mainstream healthcare and reshaping how patients receive treatment.

A new synthetic cannabinoid shows strong potential in treating cachexia — the severe weight loss associated with cancer. This breakthrough could expand medical cannabis applications and reshape how cannabinoids are used in clinical care.